Introduction
============

The prophylactic human papillomavirus (HPV) vaccine is a key component in cervical cancer control. The World Health Organization recommends the inclusion of HPV vaccines in national immunization programs \[[@b1-crt-2017-174]\]. Since 2007 and 2008, quadrivalent and bivalent HPV vaccines have been approved for use in South Korea. However, there had been no national or governmental HPV vaccination program, such as organized school-based vaccination or subsidized vaccination programs, until 2016. Thus, the vaccine coverage during this period was low (12% among adult women \[[@b2-crt-2017-174]\]; 1%-10% among high school girls \[[@b3-crt-2017-174]-[@b6-crt-2017-174]\]). Moreover, awareness regarding HPV vaccination and its effectiveness, which is an important factor that influences the voluntary reception of the vaccination, was low among adult men and women \[[@b7-crt-2017-174]\], mothers \[[@b5-crt-2017-174],[@b8-crt-2017-174]\], high-school girls \[[@b3-crt-2017-174],[@b4-crt-2017-174]\], and college students \[[@b9-crt-2017-174],[@b10-crt-2017-174]\].

Since June 2016, HPV vaccination has been included in the fully funded National Immunization Program in Korea. The quadrivalent and bivalent HPV vaccines have also been included in the National HPV vaccination program, to be administered in 2 doses, to 12-year-old girls \[[@b11-crt-2017-174]\]. Furthermore, as one of the "10 codes for cancer prevention in Korea," HPV vaccination has been recommended for cervical cancer prevention at the national level. The successful introduction and acceptance of the vaccine depends on a range of factors, including the awareness of the importance of HPV infection in cervical cancer, awareness of the use of vaccination as a preventive method, affordability of the vaccine, acceptability of the vaccine among groups, and the feasibility of delivery strategies \[[@b12-crt-2017-174]\].

Thus, assessing the level of awareness regarding the importance of HPV infection and vaccination among adults in Korea is necessary to predict the success of the national HPV vaccination program, as well as to measure the impact of previous educational campaigns. Therefore, we analyzed and compared data from nationwide population-based interview surveys conducted in 2007, when the HPV vaccination was introduced in Korea, and in 2016, when the HPV vaccination was included in the national routine vaccination program.

Materials and Methods
=====================

The first survey on the awareness of the HPV vaccination was conducted in November 2007 and the main results have been previously published \[[@b7-crt-2017-174]\]. Briefly, 1,000 randomly selected men and women over the age of 20 years in 15 of the 16 provinces in Korea responded to a face-to-face interview survey performed by trained interviewers, using a structured questionnaire. The second survey was conducted between July 5, 2016, and August 4, 2016, and involved 1,200 randomly selected men and women over the age of 20 years in the 16 provinces. The target households were randomly sampled from each district, considering the total population number, as well as the age and sex distribution in each district and province.

The second survey employed the same questionnaire used in the first survey. Participants were asked about their awareness of HPV infections, as a primary cause of cervical cancer, and their awareness of the prevention of cervical cancer via HPV vaccination. To understand the subjects' attitudes toward HPV vaccination, questions focused on five concepts were adapted from the Health Belief Model: perceived susceptibility to HPV infection, perceived severity of HPV infection, perceived benefits of HPV vaccination, perceived barriers to HPV vaccination, and cues to action for HPV vaccination \[[@b13-crt-2017-174]\]. Questions on the perceived benefits included the respondent's willingness to vaccinate themselves and their children against HPV. A second questionnaire was added to the survey, regarding the awareness of the national HPV vaccination program, targeting 12-year-old girls that commenced in June 2016. General demographic characteristics including age, sex, place of residence, level of education, occupation, and family income were also collected.

Categorical variables are presented as numbers or percentages, and differences in distributions were evaluated using the Cochrane Mantel-Haenszel chi-square test with adjustment for age group. Logistic regression analysis was used to evaluate the association between the acceptance of the HPV vaccination, and related factors such as age (20-29, 30-39, 40-49, and 50 years or older), sex, residence (metropolitan area, city, and country), education (primary school or less, middle school, high school, and college or more), and family income ("low" for family incomes less than 2,000 US dollars, "middle" for incomes between 2,000 and 4,000 US dollars, and "high" for incomes greater than 4,000 US dollars); the odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. All analyses were performed using SAS ver. 9.3 (SAS Institute Inc., Cary, NC).

This study was approved by the ethics committee of the National Cancer Center in Korea (IRB Nos. NCCNCS-07-102, NCC2016-0153).

Results
=======

[Table 1](#t1-crt-2017-174){ref-type="table"} shows the general characteristics of the respondents. The sex and regional distributions were similar in the 2007 and 2016 surveys. The respondents in the 2016 survey were more likely to be older, have higher education, and be an office worker compared to the respondents in the 2007 survey, reflecting an aging population.

[Table 2](#t2-crt-2017-174){ref-type="table"} shows the differences in awareness of and attitudes regarding HPV infection and vaccination between the 2007 and 2016 surveys. The awareness of the importance of HPV infection (35.8% in 2016) and vaccination (36.9% in 2016) were significantly increased from that in 2007 (13.3% and 8.6%, respectively) (p \< 0.001). The proportion of respondents who reported being invulnerable to HPV infection increased from 28.2% in 2007, to 42.0% in 2016. On the other hand, the proportion of respondents who reported being unsure of their vulnerability (52.3% in 2007, 37.3% in 2016) had decreased since 2007. The proportion of respondents who considered HPV infection as non-serious had increased from 8.0% to 23.7% since 2007, whereas the proportion of respondents who were uncertain about the seriousness of HPV had decreased from 59.5% to 37.3% since 2007. In addition, the willingness to be vaccinated against HPV decreased from 55.0% in 2007 to 25.8% in 2016; the proportion of those who responded with uncertainty increased from 28.3% in 2007 to 43.3% in 2016. The most common reason for refusal of vaccination was the unimportance attached to its practice (47%), followed by the lack of its awareness (32.7%), high cost (13.7%), uncertainty about its effectiveness (11.4%), and subsequent adverse reactions (9.9%). In addition, the willingness of some respondents to vaccinate their daughters (77.0% in 2007, 69.5% in 2016) and sons (73.2% in 2007, 58.3% in 2016) had decreased over the years. Among respondents who were willing, 2.7% and 0.8% had already vaccinated their daughters or sons, respectively. Only 12.1% of men and 22.0% of women knew about the free national HPV vaccination program for girls launched in June 2016.

[Table 3](#t3-crt-2017-174){ref-type="table"} shows the factors associated with the willingness of respondents to vaccinate themselves and their daughters, in the 2016 survey. In women, a higher willingness to be vaccinated was associated with younger age, higher income level, awareness of the HPV vaccine (adjusted OR, 1.3; 95% CI, 1.0 to 1.8), and perception of the seriousness of infection (adjusted OR, 2.4; 95% CI, 1.6 to 3.4). In addition, a high level of education, awareness of the importance of HPV infection (OR, 1.5; 95% CI, 1.2 to 2.0), awareness of the vaccination (OR, 1.7; 95% CI, 1.3 to 2.2), and perception of the seriousness of infection (OR, 2.5; 95% CI, 1.8 to 3.4) were positively associated with the respondents' willingness to vaccinate their daughters. Furthermore, women (adjusted OR, 1.5; 95% CI, 1.1 to 1.9) had a higher willingness to vaccinate their daughters compared to men.

Additionally, only 17% of the respondents (12.1% of men, 22.0% of women) knew about the national HPV vaccination program launched in June 2016. Women (OR, 2.3; 95% CI, 1.7 to 3.1) and respondents aged 40-49 years (OR, 1.8; 95% CI, 1.2 to 2.7) with a high level of education (OR, 4.3; 95% CI, 1.5 to 12.5 in the level of college or more compared to the level of middle school or less), awareness of HPV infection as a risk factor for cervical cancer (OR, 2.3; 95% CI, 1.7 to 3.2), and awareness of the vaccination (OR, 3.5; 95% CI, 2.5 to 4.9) were more likely to know about the National HPV Vaccination Program ([Table 4](#t4-crt-2017-174){ref-type="table"}).

Discussion
==========

The incidence and mortality rates for cervical cancer have been decreasing steadily (age-standardized incidence rate, 16.3 per 100,000 women in 1999 and 9.5 in 2013; 5-year relative survival rate, 77.5% in 1993-1995 and 80.1% in 2009-2013 \[[@b14-crt-2017-174]\]), partly due to organized cervical cancer screenings \[[@b15-crt-2017-174]\]. However, cervical cancer is still one of the 10 major female cancers in Korea. In 2014, 3,500 new cases were diagnosed and 967 women died from cervical cancer \[[@b16-crt-2017-174]\].

As well known, cervical cancer can be avoided through the prevention of HPV infections. Therefore, since 2007, safe sexual behavior has been promoted as one of the 10 codes for cancer prevention in Korea, thereby, preventing cervical cancer development via the prevention of the sexual transmission of an HPV infection. Within the same period, HPV vaccines were introduced and used in Korea, but without an organized immunization program. Thus, vaccine coverage was low due to a lack of awareness of the HPV infection and vaccination, as well as the cost of vaccination \[[@b7-crt-2017-174]\]. Subsequently, the promotion of HPV vaccination by the private sector decreased the cost of vaccination; however, this did not substantially increase vaccine coverage. According to the Korean National Immunization Survey, vaccination coverage in 2013 was 28.7%, 15.9%, and 4.6% among women aged 19-26 years, 27-39 years, and 40-59 years, respectively \[[@b2-crt-2017-174]\]. Although there is no national data on vaccine coverage in young girls, several studies have demonstrated low rates among high school girls (1%-10%) \[[@b3-crt-2017-174]-[@b6-crt-2017-174]\]. Given that HPV is a cause of cervical cancer, and a safe and effective vaccine is available, the most effective target population is young girls without any sexual experience. Thus, in 2016, the Korean government, as a part of the National Immunization Program, offered a fully funded HPV vaccination opportunity to girls aged 12 years \[[@b11-crt-2017-174]\]. Therefore, it is very important to assess the awareness of the HPV infection and vaccination in the general population, which are possible key factors affecting the acceptance of HPV vaccination.

The results of the present study demonstrate that among adults, the awareness of HPV infection as a risk factor for cervical cancer has increased since 2007. In addition, the awareness of HPV vaccination as a preventive measure for cervical cancer has increased since 2007, while the willingness of respondents to vaccinate themselves or their daughter(s) against HPV has decreased since 2007 \[[@b7-crt-2017-174]\]. One possible explanation for these findings is that an awareness has been raised by the government sector, through the dissemination of information regarding the modes of acquisition of the HPV infection, as well as the promotion of HPV testing and vaccination in the private sectors. Furthermore, available information on HPV-related issues has improved knowledge; this has reduced uncertainty and misconceptions. Among adults, correct knowledge and an improved awareness of the HPV vaccination may decrease willingness to vaccinate themselves against HPV. Many sources, including the National Cancer Information Center (<http://www.cancer.go.kr>) and the Centers for Disease Control & Prevention (<http://nip.cdc.go.kr>), continually provide reliable detailed information regarding HPV infections, cervical cancer, and the HPV vaccine. The information emphasizes the higher effectiveness of the HPV vaccine in young girls compared to middle-aged women and men. The most common reason for refusal of the HPV vaccination in the present study was the perception of some respondents that the vaccine was not necessary for them. However, men and women with a higher educational level, greater knowledge regarding HPV infection and vaccination, and greater perception of the seriousness of HPV infections had a high willingness for vaccination and were more likely to vaccinate their daughter(s) against HPV.

The results of the present study demonstrate that the overall awareness of the national HPV vaccination program is still very low; however, the awareness of the newly launched national HPV vaccination program was relatively higher in women with high educational level, and awareness of HPV infection and vaccination. Respondents aged 40-49 years reflect an age group with a high probability of having young daughters around 12 years; these were also more likely to know about the national HPV vaccination program, compared to respondents in other age groups. Other evaluated factors did not have a significant effect on the awareness of the national HPV vaccination program. To encourage HPV vaccination among young girls around 12 years of age, it appears to be necessary for the parents of these girls to receive more information regarding the national HPV vaccination program, including why a high priority is placed on this target population, for HPV vaccination, with regard to cervical cancer prevention.

A strength of this study is that data from two nationwide surveys with the same design were used, allowing easy observation of changes in awareness and acceptance of the HPV vaccination over time. The present study also has several limitations. First, the relatively small sample sizes (1,000-1,200 respondents) are not adequate to be representative of the general population in Korea. However, we randomly sampled respondents proportional to size of the population, from 16 provinces (15 provinces in 2007) across the country, who reflected the age and sex distribution in each district and province. As a result, the general characteristics of the respondents are similar to those of the Korean general population. Second, the present study did not include children or adolescents, even though they are the targeted group for HPV vaccination. Further studies on awareness and acceptance of HPV vaccination among various groups including adolescents, parents, teachers, and health professionals are needed.

In conclusion, raising the awareness of HPV infection and vaccination with the appropriate knowledge is necessary for the successful implementation of the national HPV vaccination program. Further promotion and awareness of the national HPV vaccination program could be expected to increase the vaccine coverage, which may guarantee a cervical-cancer-free generation in the future of Korea.

Conflict of interest relevant to this article was not reported.

This study was financially supported by the Ministry of Health and Welfare (1660660) and partly supported by the National Cancer Center (NCC-1610410).

###### 

General characteristics of the respondents in the 2007 and 2016 surveys

  Characteristic                                                                  Survey year   
  ------------------------------------------------------------------------------- ------------- ------------
  **Sex**                                                                                       
   Men                                                                            496 (49.6)    594 (49.5)
   Women                                                                          504 (50.4)    606 (50.5)
  **Age (yr)**                                                                                  
   20-29                                                                          222 (22.2)    196 (16.3)
   30-39                                                                          239 (23.9)    243 (20.3)
   40-49                                                                          225 (22.5)    268 (22.3)
   ≥ 50                                                                           314 (31.4)    493 (41.1)
  **Education**                                                                                 
   Middle school or less                                                          195 (19.5)    76 (6.3)
   High school                                                                    459 (45.9)    502 (41.8)
   College or more                                                                345 (34.5)    622 (51.8)
  **Occupation**                                                                                
   Agriculture/Forestry/Fishery                                                   39 (3.9)      3 (0.3)
   Self-employment                                                                217 (21.7)    152 (12.7)
   Clerk/Sale                                                                     117 (11.7)    205 (17.1)
   Engineer/Driver                                                                57 (5.7)      74 (6.2)
   Janitor/Cleaner/Construction worker                                            20 (2.0)      27 (2.2)
   Office worker                                                                  141 (14.1)    325 (27.1)
   Professional/Manager                                                           9 (0.9)       32 (2.7)
   House wife                                                                     274 (27.4)    279 (23.2)
   Student                                                                        68 (6.8)      64 (5.3)
   Unemployment                                                                   58 (5.8)      39 (3.2)
  **Household income per month^[a)](#tfn1-crt-2017-174){ref-type="table-fn"}^**                 
   Low                                                                            232 (23.2)    236 (19.7)
   Middle                                                                         562 (56.2)    685 (57.1)
   High                                                                           197 (19.7)    279 (23.2)
  **Region**                                                                                    
   Metropolitan area                                                              479 (47.9)    542 (45.2)
   City                                                                           421 (42.1)    523 (43.6)
   Country                                                                        100 (10.0)    135 (11.2)

Values are presented as number (%).

Income categorized in low (\< 2,000 USD), middle (2,000-4,000 USD), and high (\> 4,000 USD) in 2007; low (\< 3,000 USD), middle (3,000-5,000 USD), and high (\> 5,000 USD) in 2016; 1 US dollar=1,000 Korean won.

###### 

Awareness of and attitudes toward HPV infection and vaccination: the 2007 and 2016 surveys

  Variable                                                                                                                                 Overall      p-value^[a)](#tfn2-crt-2017-174){ref-type="table-fn"}^   Men        p-value^[a)](#tfn2-crt-2017-174){ref-type="table-fn"}^   Women        p-value^[a)](#tfn2-crt-2017-174){ref-type="table-fn"}^                             
  ---------------------------------------------------------------------------------------------------------------------------------------- ------------ -------------------------------------------------------- ---------- -------------------------------------------------------- ------------ -------------------------------------------------------- ------------ ------------ ----------
  **\[Awareness\] Did you know that cervical cancer is related to HPV infection?**                                                                                                                                                                                                                                                                                                   
   No                                                                                                                                      867 (86.7)   770 (64.2)                                                          459 (92.5)                                               424 (71.4)                                                            408 (80.9)   346 (57.1)   
   Yes                                                                                                                                     133 (13.3)   430 (35.8)                                               \< 0.001   37 (7.5)                                                 170 (28.6)   \< 0.001                                                 96 (19.1)    260 (42.9)   \< 0.001
  **\[Awareness\] Did you know that cervical cancer can be prevented by HPV vaccination?**                                                                                                                                                                                                                                                                                           
   No                                                                                                                                      914 (91.4)   757 (63.1)                                                          471 (95.0)                                               431 (72.6)                                                            443 (87.9)   326 (53.8)   
   Yes                                                                                                                                     86 (8.6)     443 (36.9)                                               \< 0.001   25 (5.0)                                                 163 (27.4)   \< 0.001                                                 61 (12.1)    280 (46.2)   \< 0.001
  \[Perceived susceptibility\] Do you think you can be easily infected with HPV?                                                                                                                                                                                                                                                                                                     
   No                                                                                                                                      282 (28.2)   504 (42.0)                                                          149 (30.0)                                               263 (44.3)                                                            133 (26.4)   241 (39.8)   
   Yes                                                                                                                                     195 (19.5)   308 (25.7)                                                          86 (17.3)                                                98 (16.5)                                                             109 (21.6)   210 (34.6)   
   Do not know                                                                                                                             523 (52.3)   388 (32.3)                                               \< 0.001   261 (52.6)                                               233 (39.2)   \< 0.001                                                 262 (52.0)   155 (25.6)   \< 0.001
  **\[Perceived seriousness\] Do you think HPV infection is a serious disease?**                                                                                                                                                                                                                                                                                                     
   No                                                                                                                                      80 (8.0)     284 (23.7)                                                          40 (8.1)                                                 148 (24.9)                                                            40 (7.9)     136 (22.4)   
   Yes                                                                                                                                     325 (32.5)   469 (39.1)                                                          126 (25.4)                                               193 (32.5)                                                            199 (39.5)   276 (45.5)   
   Do not know                                                                                                                             595 (59.5)   447 (37.3)                                               \< 0.001   330 (66.5)                                               253 (42.6)   \< 0.001                                                 265 (52.6)   194 (32.0)   \< 0.001
  **\[Perceived benefits\] Would you be vaccinated against HPV if HPV infection is preventable?**                                                                                                                                                                                                                                                                                    
   No                                                                                                                                      167 (16.7)   348 (30.9)                                                          71 (14.3)                                                175 (30.5)                                                            96 (19.0)    173 (31.3)   
   Yes                                                                                                                                     550 (55.0)   291 (25.8)                                                          275 (55.4)                                               144 (25.1)                                                            275 (54.6)   147 (26.6)   
   Uncertain                                                                                                                               283 (28.3)   488 (43.3)                                               \< 0.001   150 (30.2)                                               255 (44.4)   \< 0.001                                                 133 (26.4)   233 (42.1)   \< 0.001
  **\[Perceived benefits\] If HPV infection is preventable, would you vaccinate your daughter against HPV?**                                                                                                                                                                                                                                                                         
   No                                                                                                                                      46 (4.6)     115 (9.6)                                                           28 (5.6)                                                 58 (9.8)                                                              18 (3.6)     57 (9.4)     
   Yes                                                                                                                                     770 (77.0)   834 (69.5)                                                          374 (75.4)                                               391 (65.8)                                                            396 (78.6)   443 (73.1)   
    Already vaccinated                                                                                                                                  32 (2.7)                                                                                                                     9 (1.5)                                                                            23 (3.8)     
    Will vaccinated                                                                                                                                     802 (66.8)                                                                                                                   382 (64.3)                                                                         420 (69.3)   
   Uncertain                                                                                                                               184 (18.4)   251 (20.9)                                               \< 0.001   94 (19.0)                                                145 (24.4)   0.001                                                    90 (17.9)    106 (17.5)   0.001
  **\[Perceived benefits\] If HPV infection is preventable, would you vaccinate your son against HPV for your future daughter-in-law?**                                                                                                                                                                                                                                              
   No                                                                                                                                      56 (5.6)     159 (13.3)                                                          29 (5.8)                                                 79 (13.3)                                                             27 (5.4)     80 (13.2)    
   Yes                                                                                                                                     732 (73.2)   702 (58.5)                                                          352 (71.0)                                               341 (57.4)                                                            380 (75.4)   361 (59.6)   
    Already vaccinated                                                                                                                                  10 (0.8)                                                                                                                     4 (0.7)                                                                            6 (1.0)      
    Will vaccinated                                                                                                                                     692 (57.7)                                                                                                                   337 (56.7)                                                                         355 (58.6)   
   Uncertain                                                                                                                               212 (21.2)   339 (28.3)                                               \< 0.001   115 (23.2)                                               174 (29.3)   \< 0.001                                                 97 (19.2)    165 (27.2)   \< 0.001
  **\[Awareness\] Did you know that free HPV vaccination is available for girls ages 11-12 by a national immunization program in 2016?**                                                                                                                                                                                                                                             
   No                                                                                                                                                   995 (82.9)                                                                                                                   522 (87.9)                                                                         473 (78.0)   
   Yes                                                                                                                                                  205 (17.1)                                                                                                                   72 (12.1)                                                                          133 (22.0)   

Values are presented as number (%). HPV, human papillomavirus.

Cochran-Mantel-Haenszel chi-square test, adjusted for age-group.

###### 

Willingness to vaccinate oneself and respondent's daughter(s) against HPV by selected characteristics, 2016

  Characteristic                                                       Total   Willingness to vaccinate oneself^[a)](#tfn3-crt-2017-174){ref-type="table-fn"}^   Willingness to vaccinate daughter                                                
  -------------------------------------------------------------------- ------- --------------------------------------------------------------------------------- ----------------------------------- --------------- ------------ --------------- ---------------
  **Sex**                                                                                                                                                                                                                                         
   Men                                                                 594     144 (25.1)                                                                        1                                   1               391 (65.8)   1               1
   Women                                                               606     147 (26.6)                                                                        1.1 (0.9-1.5)                       1.1 (0.9-1.5)   443 (73.1)   1.4 (1.1-1.8)   1.5 (1.1-1.9)
  **Age (yr)**                                                                                                                                                                                                                                    
   ≥ 50                                                                493     101 (21.3)                                                                        1                                   1               342 (69.4)   1               1
   40-49                                                               268     70 (27.8)                                                                         1.4 (1.0-2.0)                       1.4 (1.0-2.0)   189 (70.5)   1.1 (0.8-1.5)   1.0 (0.7-1.4)
   30-39                                                               243     65 (29.3)                                                                         1.5 (1.1-2.2)                       1.5 (1.0-2.2)   170 (70.0)   1.1 (0.8-1.5)   1.0 (0.7-1.4)
   20-29                                                               196     55 (30.7)                                                                         1.7 (1.1-2.4)                       1.6 (1.1-2.5)   133 (67.9)   1.0 (0.7-1.4)   0.9 (0.6-1.3)
                                                                                                                                                                 p-trend=0.004                       p-trend=0.009                p-trend=0.926   p-trend=0.637
  **Education**                                                                                                                                                                                                                                   
   Middle school or less                                               76      16 (21.1)                                                                         1                                   1               43 (56.6)    1               1
   High school                                                         502     119 (25.1)                                                                        1.1 (0.6-2.0)                       1.1 (0.6-2.0)   363 (72.3)   2.2 (1.3-3.7)   2.2 (1.3-3.7)
   College or more                                                     622     156 (27.1)                                                                        1.1 (0.6-2.0)                       1.1 (0.6-2.0)   428 (68.8)   2.0 (1.2-3.3)   2.0 (1.2-3.3)
                                                                                                                                                                 p-trend=0.821                       p-trend=0.821                p-trend=0.308   p-trend=0.308
  **Income per month**                                                                                                                                                                                                                            
   Low (\< 3,000 USD)                                                  236     46 (20.1)                                                                         1                                   1               160 (67.8)   1               1
   Middle (3,000-5,000 USD)                                            685     168 (26.3)                                                                        1.3 (0.9-1.9)                       1.4 (0.9-2.0)   469 (68.5)   1.1 (0.8-1.5)   0.9 (0.7-1.3)
   High (\> 5,000 USD)                                                 279     77 (29.8)                                                                         1.6 (1.0-2.4)                       1.7 (1.1-2.6)   205 (73.5)   1.3 (0.9-2.0)   1.2 (0.8-1.9)
                                                                                                                                                                 p-trend=0.030                       p-trend=0.026                p-trend=0.126   p-trend=0.205
  **Region**                                                                                                                                                                                                                                      
   Metropolitan area                                                   542     135 (26.5)                                                                        1                                   1               376 (69.4)   1               1
   Middle/Small city                                                   523     132 (26.8)                                                                        1.0 (0.8-1.3)                       1.0 (0.8-1.3)   371 (70.9)   1.1 (0.8-1.4)   1.0 (0.8-1.4)
   Small town                                                          135     24 (19.4)                                                                         0.7 (0.4-1.1)                       0.7 (0.4-1.1)   87 (64.4)    0.8 (0.5-1.2)   0.7 (0.5-1.1)
                                                                                                                                                                 p-trend=0.306                       p-trend=0.297                p-trend=0.536   p-trend=0.491
  **Awareness of HPV infection as a risk factor of cervical cancer**                                                                                                                                                                              
   No                                                                  770     185 (24.4)                                                                        1                                   1               507 (65.8)   1               1
   Yes                                                                 430     106 (28.7)                                                                        1.2 (0.9-1.6)                       1.2 (0.9-1.6)   327 (76.1)   1.6 (1.2-2.1)   1.5 (1.2-2.0)
  **Awareness of HPV vaccine**                                                                                                                                                                                                                    
   No                                                                  757     173 (23.7)                                                                        1                                   1               493 (65.1)   1               1
   Yes                                                                 443     118 (29.8)                                                                        1.3 (1.0-1.8)                       1.3 (1.0-1.8)   341 (77.0)   1.8 (1.3-2.2)   1.7 (1.3-2.2)
  **Perceived seriousness**                                                                                                                                                                                                                       
   No                                                                  284     47 (17.5)                                                                         1                                   1               172 (60.6)   1               1
   Yes                                                                 469     145 (33.6)                                                                        2.4 (1.6-3.4)                       2.4 (1.6-3.4)   375 (80.0)   2.5 (1.8-3.5)   2.5 (1.8-3.4)
   Do not know                                                         447     99 (23.2)                                                                         1.4 (1.0-2.1)                       1.4 (1.0-2.1)   287 (64.2)   1.2 (0.9-1.6)   1.2 (0.9-1.6)
  **Awareness on NHPVP**                                                                                                                                                                                                                          
   No                                                                  995     239 (25.1)                                                                        1                                   1               682 (68.5)   1               1
   Yes                                                                 205     52 (29.9)                                                                         1.2 (0.8-1.7)                       1.2 (0.8-1.7)   152 (74.2)   1.2 (0.9-1.8)   1.2 (0.9-1.7)

HPV, human papillomavirus; OR, odds ratio; CI, confidence interval; NHPVP, National HPV Vaccination Program.

The willingness to vaccinate oneself was analyzed except for 73 persons who had already received HPV vaccination before the survey,

Model 1: multiple logistic regression model adjusted for sex and age,

Model 2: multiple logistic regression model adjusted for sex, age, and education, when appropriate.

###### 

Awareness of the national HPV vaccination program by selected characteristics, 2016

  Characteristic                                                       Total   Awareness of the National HPV Vaccination Program                      
  -------------------------------------------------------------------- ------- --------------------------------------------------- ------------------ ------------------
  **Sex**                                                                                                                                             
   Men                                                                 594     72 (12.1)                                           1                  1
   Women                                                               606     133 (21.9)                                          2.1 (1.6-2.9)      2.3 (1.7-3.1)
  **Age (yr)**                                                                                                                                        
   ≥ 50                                                                493     61 (12.4)                                           1                  1
   40-49                                                               268     58 (21.6)                                           2.1 (1.4-3.1)      1.8 (1.2-2.7)
   30-39                                                               243     47 (19.3)                                           1.8 (1.2-2.7)      1.4 (0.9-2.2)
   20-29                                                               196     39 (19.9)                                           1.9 (1.2-3.0)      1.4 (0.9-2.3)
                                                                                                                                   p-trend=0.002      p-trend=0.130
  **Education**                                                                                                                                       
   Middle school or less                                               76      4 (5.3)                                             1                  1
   High school                                                         502     74 (14.7)                                           2.9 (1.0-8.4)      2.9 (1.0-8.4)
   College or more                                                     622     127 (20.4)                                          4.3 (1.5-12.5)     4.3 (1.5-12.5)
                                                                                                                                   p-trend \< 0.001   p-trend \< 0.001
  **Income per month**                                                                                                                                
   Low (\< 3,000 USD)                                                  236     35 (14.8)                                           1                  1
   Middle (3,000-5,000 USD)                                            685     119 (17.4)                                          1.1 (0.7-1.7)      0.9 (0.6-1.4)
   High (\> 5,000 USD)                                                 279     51 (18.3)                                           1.2 (0.7-1.9)      0.9 (0.5-1.4)
                                                                                                                                   p-trend=0.422      p-trend=0.720
  **Region**                                                                                                                                          
   Metropolitan area                                                   542     81 (14.9)                                           1                  1
   Middle/Small city                                                   523     103 (19.7)                                          1.4 (1.0-2.0)      1.4 (1.0-1.9)
   Small town                                                          135     21 (15.6)                                           1.0 (0.6-1.8)      1.0 (0.6-1.7)
                                                                                                                                   p-trend=0.226      p-trend=0.324
  **Awareness of HPV infection as a risk factor of cervical cancer**                                                                                  
   No                                                                  770     90 (11.7)                                           1                  1
   Yes                                                                 430     115 (26.7)                                          2.4 (1.7-3.3)      2.3 (1.7-3.2)
  **Awareness of HPV vaccine**                                                                                                                        
   No                                                                  757     73 (9.6)                                            1                  1
   Yes                                                                 443     132 (29.8)                                          3.6 (2.6-4.9)      3.5 (2.5-4.9)
  **Perceived seriousness**                                                                                                                           
   No                                                                  284     44 (15.5)                                           1                  1
   Yes                                                                 469     101 (21.5)                                          1.4 (0.9-2.1)      1.4 (0.9-2.0)
   Do not know                                                         447     60 (13.4)                                           0.9 (0.6-1.4)      0.9 (0.6-1.4)

HPV, human papillomavirus; OR, odds ratio; CI, confidence interval.

Model 1: multiple logistic regression model adjusted for sex and age,

Model 2: multiple logistic regression model adjusted for sex, age and education, when appropriate.
